Analysis of the heteroplasmy level and transmitted features in hearing-loss pedigrees with mitochondrial 12S rRNA A1555G mutation

BMC Genetics

Pu Dai²  Suoqiang Zhai¹  Huijun Yuan¹  Yu Su¹  Yongyi Yuan¹  Guojian Wang²  Mingyu Han²  Dongyang Kang¹  Shasha Huang¹  Yuhua Zhu¹ 

[1] Department of Otorhinolaryngology, Head and Neck Surgery, PLA General Hospital, 28# Fuxing Road, Beijing 100853, P. R. China;Department of Otolaryngology, Hainan Branch of PLA General Hospital, Haitang Bay, Sanya 572000, P. R. China

关键词: A1555G mutation;    Heteroplasmy;    Mitochondrial DNA;    Hearing loss;   

Others  :  1085758
DOI  :  10.1186/1471-2156-15-26

 received in 2013-11-03, accepted in 2014-02-12,  发布年份 2014

【 摘 要 】

Background

Mitochondrial cytopathies are characterized by a large variability of clinical phenotypes and severity. The amount of mutant mitochondrial DNA (mtDNA) in a cell, called the heteroplasmy level, is an important determinant of the degree of mitochondrial dysfunction and therefore disease severity. Understanding the distribution of heteroplasmy levels across a group of offspring is an important step in understanding the inheritance of diseases. Recently, the mtDNA A1555G mutation was found to be associated with non-syndromic and drug-induced hearing loss.

Results

Here, we report five pedigrees with multiple members having the A1555G mutation and showing diverse clinical manifestations and different heteroplasmy levels. Clinical evaluations revealed that the hearing impairment phenotypes varied with respect to the severity of hearing loss, age of onset of hearing loss, and pattern of audiometric configuration. These five Chinese pedigrees had different penetrance of hearing loss, ranging from 10–52%. A molecular study showed that the average heteroplasmy rates of the five pedigrees were 31.98% (0–91.35%), 78.28% (32.8–96.08%), 87.99% (82.32–94.65%), 93.34% (91.02–95.05%), and 93.57% (91.38–94.24%). There was no gradual tendency of heteroplasmy to increase or decrease along with transmission. A study of the relationship between clinical features and genetic background found that the percentage of deafness was 0 when the heteroplasmy level was less than 50%, 25% when the heteroplasmy level was 50–80%, 47.06% when the heteroplasmy level was 80–90%, and 57.58% when the heteroplasmy level exceeded 90%. The risk of deafness rose with the heteroplasmy level.

Conclusions

The results suggest that there are large random shifts in the heteroplasmy level between mothers and offspring with the A1555G mutation; heteroplasmy could disappear randomly when the heteroplasmy level of the pedigree was low enough, and no regular pattern was found. The heteroplasmy level may be one of the factors influencing the penetrance of deafness caused by the mtDNA A1555G mutation.

【 授权许可】

   
2014 Zhu et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Dzhemileva LU, Posukh OL, Tazetdinov AM, Barashkov NA, Zhuravskiĭ SG, Ponidelko SN, Markova TG, Tadinova VN, Fedorova SA, Maksimova NR, Khusnutdinova EK: Analysis of mitochondrial 12S rRNA and tRNA(Ser(UCN)) genes in patients with nonsyndromic sensorineural hearing loss from various regions of Russia. Genetika 2009, 45(7):982-991.
• [2]Human H, Lombard D, de Jong G, Bardien S: A South African family with the mitochondrial A1555G mutation on haplogroup L0d. Biochem Biophys Res Commun 2009, 382(2):390-394.
• [3]Bai Y, Wang Z, Dai W, Li Q, Chen G, Cong N, Guan M, Li H: A six-generation Chinese family in haplogroup B4C1C exhibits high penetrance of 1555A > G-induced hearing Loss. BMC Med Genet 2010, 11:129. BioMed Central Full Text
• [4]Bae JW, Kim DB, Choi JY, Park HJ, Lee JD, Hur DG, Bae SH, da Jung J, Lee SH, Kim UK, Lee KY: Molecular and clinical characterization of the variable phenotype in Korean families with hearing loss associated with the mitochondrial A1555G mutation. PLoS One 2012, 7(8):42463.
• [5]de Moraes VC, Alexandrino F, Andrade PB, Câmara MF, Sartorato EL: Study of modifiers factors associated to mitochondrial mutations in individuals with hearing impairment. Biochem Biophys Res Commun 2009, 381(2):210-213.
• [6]Ding Y, Li Y, You J, Yang L, Chen B, Lu J, Guan MX: Mitochondrial tRNA(Glu) A14693G variant may modulate the phenotypic manifestation of deafness-associated 12S rRNA A1555G mutation in a Han Chinese family. J Genet Genomics 2009, 36(4):241-250.
• [7]Qian Y, Guan MX: Interaction of aminoglycosides with human mitochondrial 12S rRNA carrying the deafness-associated mutation. Antimicrob Agents Chemother 2009, 53(11):4612-4618.
• [8]Lu J, Qian Y, Li Z, Yang A, Zhu Y, Li R, Yang L, Tang X, Chen B, Ding Y, Li Y, You J, Zheng J, Tao Z, Zhao F, Wang J, Sun D, Zhao J, Meng Y, Guan MX: Mitochondrial haplotypes may modulate the phenotypic manifestation of the deafness-associated 12S rRNA 1555A > G mutation. Mitochondrion 2010, 10(1):69-81.
• [9]Guan MX: Mitochondrial 12S rRNA mutations associated with aminoglycoside ototoxicity. Mitochondrion 2011, 11(2):237-245.
• [10]Yuan H, Qian Y, Xu Y, Cao J, Bai L, Shen W, Ji F, Zhang X, Kang D, Mo JQ, Greinwald JH, Han D, Zhai S, Young WY, Guan MX: Cosegregation of the G7444A mutation in the mitochondrial COI/tRNA(Ser(UCN)) genes with the 12S rRNA A1555G mutation in a Chinese family with aminoglycoside-induced and non-syndromic hearing loss. Am J Med Genet A 2005, 138A(2):133-140.
• [11]Young WY, Zhao L, Qian Y, Li R, Chen J, Yuan H, Dai P, Zhai S, Han D, Guan MX: Variants in mitochondrial tRNAGlu, tRNAArg, and tRNAThr may influence the phenotypic manifestation of deafness associated 12S rRNA A1555G mutation in three Han Chinese families with hearing loss. Am J Med Genet A 2006, 140(20):2188-2197.
• [12]del Castillo FJ, Rodríguez-Ballesteros M, Martín Y, Arellano B, Gallo-Terán J, Morales-Angulo C, Ramírez-Camacho R, Cruz Tapia M, Solanellas J, Martínez-Conde A, Villamar M, Moreno-Pelayo MA, Moreno F, del Castillo I: Heteroplasmy for the 1555A > G mutation in the mitochondrial 12S rRNA gene in six Spanish families with non-syndromic hearing loss. J Med Genet 2003, 40(8):632-636.
• [13]Wonnapinij P, Chinnery PF, Samuels DC: The distribution of mitochondrial DNA heteroplasmy due to random genetic drift. Am J Hum Genet 2008, 83(5):582-593.
• [14]Poulton J, Chiaratti MR, Meirelles FV, Kennedy S, Wells D, Holt IJ: Transmission of mitochondrial DNA diseases and ways to prevent them. PloS Genet 2010, 6(8):e1001066.
• [15]Rieder MJ, Taylor SL, Tobe VO, Nickerson DA: Automating the identification of DNA variations using quality-based fluorescence resequencing: analysis of the human mitochondrial genome. Nucleic Acid Res 1998, 26(4):967-973.
• [16]Bardien S, Human H, Harris T, Hefke G, Veikondis R, Schaaf HS, van der Merwe L, Greinwald JH, Fagan J, de Jong G: A rapid method for detection of five known mutations associated with aminoglycoside-induced deafness. BMC Med Genet 2009, 10:2.
• [17]Wu CC, Lu YC, Chen PJ, Liu AY, Hwu WL, Hsu CJ: Application of SNaPshot multiplex assays for simultaneous multigene mutation screening in patients with idiopathic sensorineural hearing impairment. Laryngoscope 2009, 119(12):2411-2416.
• [18]Cassandrini D, Calevo MG, Tessa A, Manfredi G, Fattori F, Meschini MC, Carrozzo R, Tonoli E, Pedemonte M, Minetti C, Zara F, Santorelli FM, Bruno C: A new method for analysis of mitochondrial DNA point mutations and assess levels of heteroplasmy. Biochem Biophys Res Commun 2006, 342(2):387-393.
• [19]Finsterer J: Genetic, pathogenetic, and phenotypic implications of the mitochondrial A3243G tRNALeu(UUR) mutation. Acta Neurol Scand 2007, 116(1):1-14.
• [20]Poulton J: Transmission of mtDNA: cracks in the bottleneck. Am J Hum Genet 1995, 57(2):224-226.
• [21]Poulton J, Macaulay V, Marchington DR: Mitochondrial genetics ‘98 is the bottleneck cracked? Am J Hum Genet 1998, 62(4):752-757.